Search research articles
Contact Us
Filters
Showing results (371-380 of 437) with videos related to
Page
of 44
Sort By:
Cancer Research Communications
|
February 23, 2024
The NUTRIENT Trial (NUTRitional Intervention among myEloproliferative Neoplasms): Results from a Randomized Phase I Pilot Study for Feasibility and Adherence
Laura F Mendez Luque, Julio Avelar-Barragan, Hellen Nguyen, et al.
Medrxiv : the Preprint Server for Health Sciences
|
May 22, 2023
The NUTRIENT Trial (NUTRitional Intervention among myEloproliferative Neoplasms): Feasibility Phase
Laura F Mendez Luque, Julio Avelar-Barragan, Hellen Nguyen, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences
|
March 26, 2025
Hyperorality in Frontotemporal Dementia: How Psychiatric and Neural Correlates Change During the Disease Course
Christopher B Morrow, Chiadi Onyike, Alexander Pantelyat, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
January 1, 2013
Shining a light on posterior cortical atrophy
Sebastian J Crutch, Jonathan M Schott, Gil D Rabinovici, et al.
Alzheimer Disease and Associated Disorders
|
March 23, 2013
Neurodegenerative disease phenotypes in carriers of MAPT p.A152T, a risk factor for frontotemporal dementia spectrum disorders and Alzheimer disease
Suzee E Lee, Maria C Tartaglia, Görsev Yener, et al.
Neurology Open Access
|
April 16, 2026
Continuous At-Home Monitoring of Nighttime Bed Behavior in Frontotemporal Dementia
Emily W Paolillo, Amy Wise, Jeffrey A Kaye, et al.
The Lancet. Neurology
|
January 25, 2025
Intranasal oxytocin for apathy in people with frontotemporal dementia (FOXY): a multicentre, randomised, double-blind, placebo-controlled, adaptive, crossover, phase 2a/2b superiority trial
Kristy K L Coleman, Scott Berry, Jeffrey Cummings, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
March 28, 2023
Plasma inflammation for predicting phenotypic conversion and clinical progression of autosomal dominant frontotemporal lobar degeneration
Breton M Asken, Peter A Ljubenkov, Adam M Staffaroni, et al.
Neurology
|
May 3, 2013
Interrater reliability of the new criteria for behavioral variant frontotemporal dementia
Amanda K Lamarre, Katya Rascovsky, Alan Bostrom, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 2, 2021
The contribution of behavioral features to caregiver burden in FTLD spectrum disorders
Hannah E Silverman, Jeannie M Ake, Masood Manoochehri, et al.
Page
of 44
Search research articles
Search
Showing results (371-380 of 437) with videos related to
Sort By:
Page
of 44
Cancer Research Communications
|
February 23, 2024
The NUTRIENT Trial (NUTRitional Intervention among myEloproliferative Neoplasms): Results from a Randomized Phase I Pilot Study for Feasibility and Adherence
Laura F Mendez Luque, Julio Avelar-Barragan, Hellen Nguyen, et al.
Medrxiv : the Preprint Server for Health Sciences
|
May 22, 2023
The NUTRIENT Trial (NUTRitional Intervention among myEloproliferative Neoplasms): Feasibility Phase
Laura F Mendez Luque, Julio Avelar-Barragan, Hellen Nguyen, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences
|
March 26, 2025
Hyperorality in Frontotemporal Dementia: How Psychiatric and Neural Correlates Change During the Disease Course
Christopher B Morrow, Chiadi Onyike, Alexander Pantelyat, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
January 1, 2013
Shining a light on posterior cortical atrophy
Sebastian J Crutch, Jonathan M Schott, Gil D Rabinovici, et al.
Alzheimer Disease and Associated Disorders
|
March 23, 2013
Neurodegenerative disease phenotypes in carriers of MAPT p.A152T, a risk factor for frontotemporal dementia spectrum disorders and Alzheimer disease
Suzee E Lee, Maria C Tartaglia, Görsev Yener, et al.
Neurology Open Access
|
April 16, 2026
Continuous At-Home Monitoring of Nighttime Bed Behavior in Frontotemporal Dementia
Emily W Paolillo, Amy Wise, Jeffrey A Kaye, et al.
The Lancet. Neurology
|
January 25, 2025
Intranasal oxytocin for apathy in people with frontotemporal dementia (FOXY): a multicentre, randomised, double-blind, placebo-controlled, adaptive, crossover, phase 2a/2b superiority trial
Kristy K L Coleman, Scott Berry, Jeffrey Cummings, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
March 28, 2023
Plasma inflammation for predicting phenotypic conversion and clinical progression of autosomal dominant frontotemporal lobar degeneration
Breton M Asken, Peter A Ljubenkov, Adam M Staffaroni, et al.
Neurology
|
May 3, 2013
Interrater reliability of the new criteria for behavioral variant frontotemporal dementia
Amanda K Lamarre, Katya Rascovsky, Alan Bostrom, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 2, 2021
The contribution of behavioral features to caregiver burden in FTLD spectrum disorders
Hannah E Silverman, Jeannie M Ake, Masood Manoochehri, et al.
Page
of 44